Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia

Blood

Volumn 99, Issue 6, 2002, Pages 1952-1958

  Dworzak, Michael N ^a   Fröschl, Gertraud ^a   Printz, Dieter ^a   Mann, Georg ^a   Pötschger, Ulrike ^a   Mühlegger, Nora ^a   Fritsch, Gerhard ^a   Gadner, Helmut ^a  

^a ST ANNA CHILDREN S HOSPITAL   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; CYTARABINE; MERCAPTOPURINE; METHOTREXATE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ARTICLE; BLAST CELL; BONE MARROW EXAMINATION; CANCER DIAGNOSIS; CANCER RECURRENCE; CELL COUNT; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DISEASE COURSE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; INFANT; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; STANDARDIZATION;

EID: 0037085750     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.6.1952     Document Type: Article

References (30)

1. New definition of remission in childhood acute lymphoblastic leukemia
2. Detection of minimal residual disease in B-lineage acute lymphoblastic leukaemia by quantitative flow cytometry
3. Leukaemia-associated immunophenotypes (LAIP) are observed in 90% of adult and childhood acute lymphoblastic leukaemia: Detection in remission marrow predicts outcome
4. Comparative phenotype mapping of normal vs. malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations
5. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: Method and significance
6. A limited antibody panel can distinguish B-precursor acute lymphoblastic leukemia from normal B precursors with four color flow cytometry: Implications for residual disease detection
7. Prognostic value of immunophenotypic detection of minimal residual disease in acute lymphoblastic leukemia
8. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
9. Clinical importance of minimal residual disease in childhood acute lymphoblastic leukemia
10. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
11. Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood
12. Tandem application of flow cytometry and polymerase chain reaction for comprehensive detection of minimal residual disease in childhood acute lymphoblastic leukemia
13. Detection of residual disease in pediatric B-cell precursor acute lymphoblastic leukemia by comparative phenotype mapping: A study of five cases controlled by genetic methods
14. Immunological monitoring of residual disease in treated thymic acute lymphoblastic leukemia
15. Detection of minimal residual acute lymphoblastic leukemia by immunological marker analysis: Possibilities and limitations
16. The immunologic detection of minimal residual disease in acute leukemia
17. Detection of minimal residual disease in acute leukemia: Methodologic advances and clinical significance
18. Differential expression of CD3 and CD7 in T-cell malignancies: A quantitative study by flow cytometry
19. Resultate der Studie ALL-BFM 90 und erstes Zwischenergebnis der Studie ALL-BFM 95
20. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: Results of trial ALL-BFM 90
21. Multiparameter phenotype mapping of normal and post-chemotherapy B lymphopoiesis in pediatric bone marrow
22. Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow: CB79a expression precedes CD19 in early B-cell ontogeny
23. Flow cytometric analysis of normal B cell differentiation: A frame of reference for the detection of minimal residual disease in precursor-B-ALL
24. Identification and characterization of plasma cells in normal human bone marrow by high-resolution flow cytometry
25. Nonparametric estimation from incomplete observations
26. Regression models and live tables
27. Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia
28. Outcome prediction by means of MRD at the end of induction therapy in childhood acute lymphoblastic leukemia strongly depends on the therapeutic regimen: A report from the German COALL study
29. Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy
30. Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: Implications for monitoring of minimal residual disease